DexCom, Inc.

NASDAQ:DXCM

Medical - Devices

Healthcare
$82.52 +1.27%

+$0.90 today

Market cap
$30.78B
Beta
1.44
P/E (TTM)
29.9
EPS (TTM)
$2.42
52W Low $54.11High $89.98

Volume 4.25M

Average 5.43M

DXCM Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

DexCom, Inc.NASDAQ: DXCM

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 63.4%

Gross margin was 63.4% in Q2 FY2026, up 3.9 pp from a year earlier. On a trailing-twelve-month basis it was 62.5%, up 3.7 pp year over year. Over 3 fiscal years it narrowed by 4.6 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
63.4%+0.5 pp QoQ
Last fiscal yearDec 2025
60.1%-0.4 pp YoY
LTMJun 2026
62.5%+3.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.9 pp——
1 year-0.4 pp——
3 years-4.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
60.1%
Year-over-year change
-0.4pp

Gross Margin vs competitors

How DXCM compares with its peers on the latest reported figures

  • DXCM's LTM Jun 2026 gross margin of 62.5% is the 2nd highest of the 7 companies compared; the peer median is 55.7%.
  • Its year-over-year change of +3.7 pp is the 3rd highest of 6, against a peer median of +3.2 pp.
  • Over three fiscal years its change of -4.6 pp compares with a peer median of +5.3 pp.
DXCM Competitors Peer median
Gross Margin for DXCM and competitors
Company Period LTM level YoY 3-year change
PODDInsulet CorporationLTM Jun 202671.1% +0.3 pp+9.9 pp
DXCMDexCom, Inc.LTM Jun 202662.5% +3.7 pp-4.6 pp
BBNXBeta Bionics, Inc.LTM Mar 202657.2% +3.2 pp-44.6 pp
DRIODarioHealth Corp.LTM Mar 202656.5% -9.7 pp+21.7 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 202654.9% +8.4 pp+0.8 pp
MMEDMiniMed Group, Inc. Common StockLTM Jul 202653.8% —-4.1 pp
SENSSenseonics Holdings, Inc.LTM Mar 202652.1% +44.9 pp+28.1 pp
MMEDVMiniMed Group, Inc.—— ——
Peer median (excluding DXCM) 55.7%+3.2 pp+5.3 pp

Competitors are the stored peer set for DXCM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.45B2.91B3.62B4.03B4.66B
Cost of Revenue768M1.03B1.33B1.59B1.86B
Gross Profit1.68B1.88B2.29B2.44B2.8B
Gross Margin68.6%64.7%63.2%60.5%60.1%
Research & Development604.2M484.2M505.8M552.4M599.1M
Selling, General & Admin810.5M1.01B1.19B1.29B1.29B
Operating Expenses1.41B1.49B1.69B1.84B1.89B
Depreciation & Amortization102M155.9M186M217.7M251.8M
EBITDA377.6M565.3M916.7M945.7M1.36B
EBITDA Margin15.4%19.4%25.3%23.4%29.1%
Operating Income265.8M391.2M597.7M600M911.8M
Operating Margin10.9%13.4%16.5%14.9%19.6%
Interest Income1.7M23.8M135M134.2M112.7M
Interest Expense18.8M18.6M20.3M19M18.3M
Other Income / Expenses(9M)(400K)112.7M109M176.6M
Income Before Tax256.8M390.8M710.4M709M1.09B
Pre-Tax Margin10.5%13.4%19.6%17.6%23.3%
Income Tax Expense39.9M49.6M168.9M132.8M252.1M
Net Income216.9M341.2M541.5M576.2M836.3M
Net Margin8.9%11.7%14.9%14.3%17.9%
EPS (Basic)0.560.881.441.462.14
EPS (Diluted)0.510.801.301.422.09
Weighted Avg Shares386.9M389.4M386M404.63M390.2M
Weighted Avg Shares (Diluted)428.8M427.5M425.5M412.7M405.5M

DexCom, Inc.

NASDAQ:DXCM

Intrinsic Alpha fair value

Locked

Current Price

$82.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.